T. Rowe Price Value Z (TRZAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
52.17
+0.14 (0.27%)
Nov 29, 2024, 9:30 AM EST
24.81% (1Y)
| Fund Assets | 30.57B |
| Expense Ratio | n/a |
| Min. Investment | $2,500 |
| Turnover | 62.30% |
| Dividend (ttm) | 1.54 |
| Dividend Yield | 2.95% |
| Dividend Growth | -63.60% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 13, 2023 |
| Previous Close | 52.03 |
| YTD Return | 24.63% |
| 1-Year Return | 29.49% |
| 5-Year Return | n/a |
| 52-Week Low | 41.01 |
| 52-Week High | 52.17 |
| Beta (5Y) | n/a |
| Holdings | 113 |
| Inception Date | Mar 16, 2020 |
About TRZAX
At least 65% of the fund's total assets are normally be invested in common stocks that the portfolio manager regards as undervalued. The fund may purchase stocks issued by companies of any size, but typically focuses its investments on large-cap stocks.
Fund Family T. Rowe Price
Category Large Value
Performance Rating Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol TRZAX
Index Russell 1000 Value TR
Performance
TRZAX had a total return of 29.49% in the past year. Since the fund's inception, the average annual return has been 23.43%, including dividends.
Top 10 Holdings
23.37% of assets| Name | Symbol | Weight |
|---|---|---|
| Berkshire Hathaway Inc. | BRK.B | 3.66% |
| JPMorgan Chase & Co. | JPM | 3.02% |
| Kenvue Inc. | KVUE | 2.90% |
| Johnson & Johnson | JNJ | 2.38% |
| UnitedHealth Group Incorporated | UNH | 2.25% |
| Bank of America Corporation | BAC | 1.98% |
| Elevance Health, Inc. | ELV | 1.90% |
| The Charles Schwab Corporation | SCHW | 1.84% |
| Fiserv, Inc. | FI | 1.79% |
| AstraZeneca PLC | AZN | 1.64% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 13, 2023 | $1.5377 | Dec 14, 2023 |
| Dec 13, 2022 | $4.2243 | Dec 14, 2022 |
| Dec 14, 2021 | $5.540 | Dec 15, 2021 |
| Dec 14, 2020 | $1.275 | Dec 15, 2020 |